Inhibition of amyloid-β plaque formation by α-synuclein

被引：0
|
作者：
Teresa Bachhuber
Natalie Katzmarski
Joanna F McCarter
Desiree Loreth
Sabina Tahirovic
Frits Kamp
Claudia Abou-Ajram
Brigitte Nuscher
Alberto Serrano-Pozo
Alexandra Müller
Marco Prinz
Harald Steiner
Bradley T Hyman
Christian Haass
Melanie Meyer-Luehmann
机构：
[1] Adolf Butenandt Institute,Department of Biochemistry
[2] Ludwig-Maximilians University,Department of Neurology
[3] Neurocenter,Department of Metabolic Biochemistry
[4] University of Freiburg,undefined
[5] Faculty of Biology,undefined
[6] University of Freiburg,undefined
[7] German Center for Neurodegenerative Diseases (DZNE),undefined
[8] Ludwig-Maximilians University,undefined
[9] MassGeneral Institute for Neurodegenerative Disease,undefined
[10] Massachusetts General Hospital and Harvard Medical School,undefined
[11] Institute of Neuropathology,undefined
[12] University of Freiburg,undefined
[13] Centre for Biological Signalling Studies (BIOSS),undefined
[14] University of Freiburg,undefined
[15] Munich Cluster for Systems Neurology (SyNergy),undefined
来源：
Nature Medicine | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The introduction of α-synuclein into mouse models of Alzheimer's disease, either by intracerebral injection or transgenic overexpression, is found to inhibit the formation of hippocampal amyloid-β plaques.
引用
收藏
页码：802 / 807
页数：5
相关论文
共 50 条
  • [31] α-synuclein induced synapse damage is enhanced by amyloid-β1-42
    Clive Bate
    Steve Gentleman
    Alun Williams
    Molecular Neurodegeneration, 5
  • [32] Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders
    Elvira Valera
    Brian Spencer
    Eliezer Masliah
    Neurotherapeutics, 2016, 13 : 179 - 189
  • [33] The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy
    Piccarducci, Rebecca
    Caselli, Maria Chiara
    Zappelli, Elisa
    Ulivi, Leonardo
    Daniele, Simona
    Siciliano, Gabriele
    Ceravolo, Roberto
    Mancuso, Michelangelo
    Baldacci, Filippo
    Martini, Claudia
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 89 (03) : 1039 - 1049
  • [34] Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
    Irwin, David J.
    Lee, Virginia M. -Y.
    Trojanowski, John Q.
    NATURE REVIEWS NEUROSCIENCE, 2013, 14 (09) : 626 - 636
  • [35] Effects of Stress and Stress Hormones on Amyloid-β Protein and Plaque Deposition
    Dong, Hongxin
    Csernansky, John G.
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (02) : 459 - 469
  • [36] EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
    Bieschke, Jan
    Russ, Jenny
    Friedrich, Ralf P.
    Ehrnhoefer, Dagmar E.
    Wobst, Heike
    Neugebauer, Katja
    Wanker, Erich E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (17) : 7710 - 7715
  • [37] The inhibition of cellular toxicity of amyloid-β by dissociated transthyretin
    Cao, Qin
    Anderson, Daniel H.
    Liang, Wilson Y.
    Chou, Joshua
    Saelices, Lorena
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (41) : 14015 - 14024
  • [38] α-synuclein induced synapse damage is enhanced by amyloid-β1-42
    Bate, Clive
    Gentleman, Steve
    Williams, Alun
    MOLECULAR NEURODEGENERATION, 2010, 5
  • [39] Plaque attack: Microglia have hard feelings toward amyloid-β
    Davis, Harvey
    Attwell, David
    NEURON, 2023, 111 (01)
  • [40] Inhibition of Amyloid-β Aggregation in Alzheimer's Disease
    Wang, Qiuming
    Yu, Xiang
    Li, Lingyan
    Zheng, Jie
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (08) : 1223 - 1243
12345